Clinical Trials Browser

Phase 2/3 × Urinary Bladder Neoplasms × pembrolizumab × Clear all

NCT06225596 2026-02-17

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Phase 2/3 Recruiting

Urinary Bladder Neoplasms